Cognitive deficits in adult patients with brain tumours

Lancet Neurology

Volumn 3, Issue 3, 2004, Pages 159-168

  Taphoorn, Martin J B ^a,b   Klein, Martin ^c  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ALPHA INTERFERON; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DIETHYLCARBAMAZINE; ETIRACETAM; LAMOTRIGINE; LOMUSTINE; METHOTREXATE; METHYLPHENIDATE; PHENYTOIN; PROCARBAZINE; TEMOZOLOMIDE; THIOTEPA; TOPIRAMATE; VALPROIC ACID; VINCRISTINE;

AMNESIA; ATTENTION DEFICIT DISORDER; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN DISEASE; BRAIN LYMPHOMA; BRAIN METASTASIS; BRAIN SURGERY; BRAIN TUMOR; BRAIN VENTRICLE PERITONEUM SHUNT; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONFUSION; DEMENTIA; DEPRESSION; DISEASE SEVERITY; DRUG BRAIN LEVEL; ENDOCRINE DISEASE; EPILEPSY; EXTRAPYRAMIDAL SYMPTOM; FEAR; FOLLOW UP; GLIOMA; HUMAN; HYALINE DEGENERATION; HYPERBARIC OXYGEN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEUKEMIA; LEUKOENCEPHALOPATHY; MOOD DISORDER; NASOPHARYNX CANCER; NEUROTOXICITY; OXYGEN THERAPY; PERIPHERAL NEUROPATHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION NECROSIS; REVIEW; RISK FACTOR; SEIZURE; SIDE EFFECT; TREATMENT OUTCOME; WHITE MATTER;

EID: 1242293801     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00680-5     Document Type: Review

References (132)

1. Levisohn L., Cronin-Golomb A., Schmahmann J.D. Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain. 123:2000;1041-1050.
2. Heimans J.J., Taphoorn MJB. Impact of brain tumour treatment on quality of life. J Neurol. 249:2002;955-960.
3. Meyers C.A., Hess K.R. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro-oncol. 5:2003;89-95.
4. Weitzner M.A., Meyers C.A. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology. 6:1997;169-177.
5. Wessels P.H., Weber W.E., Raven G., Ramaekers F.C., Hopman A.H., Twijnstra A. Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol. 2:2003;395-403.
6. van den Bent M.J., Taphoorn M.J., Brandes A.A., et al. Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol. 21:2003;2525-2528.
7. van den Bent M.J., Kros J.M., Heimans J.J., et al. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Neurology. 51:1998;1140-1145.
8. Meyers C.A., Hess K.R., Yung W.K., Levin V.A. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol. 18:2000;646-650.
9. Klein M., Postma T.J., Taphoorn M.J.B., et al. The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology. 61:2003;1796-1799.
10. Armstrong C.L., Goldstein B., Shera D., Ledakis G.E., Tallent E.M. The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumor recurrence. Cancer. 97:2003;649-656.
11. Pringle A.M., Taylor R., Whittle I.R. Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg. 13:1999;46-51.
12. Meyers C.A., Berman S.A., Scheibel R.S., Hayman A. Case report: acquired antisocial personality disorder associated with unilateral left orbital frontal lobe damage. J Psychiatry Neurosci. 17:1992;121-125.
13. Klein M., Engelberts N.H.J., Van der Ploeg H.M., et al. Epilepsy in low-grade gliomas: the impact on cognitive functioning and quality of life. Ann Neurol. 54:2003;514-520.
14. Klein M., Heimans J.J., Aaronson N.K., et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 360:2002;1361-1368.
15. Klein M., Taphoorn M.J., Heimans J.J., et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 19:2001;4037-4047.
16. Schenkenberg T., Bradford D.C., Ajax E.T. Line bisection and unilateral visual neglect in patients with neurologic impairment. Neurology. 30:1989;509-517.
17. Benton A.L., van Allen M.W. Impairment in facial recognition in patients with cerebral disease. Cortex. 4:1968;344-358.
18. Benton A.L., Hannay H.J., Varney N.R. Visual perception of line direction in patients with unilateral brain disease. Neurology. 25:1975;907-910.
19. Wechsler D. WAIS-R Manual. 1981;Psychological Corp, New York.
20. Smith A. Symbol digit modalities test (SDMT) manual (revised). 1982;Western Psychological Services, Los Angeles.
21. Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France, 1964.
22. Lezak M.D. Neuropsychological assessment. 3rd edn:1995;Oxford University Press, New York.
23. Nelson H.E. The national adult reading test (NART): test manual. 1982;NFER-Nelson, Windsor, UK.
24. Stebbins G.T., Wilson R.S., Gilley D.W., Bernard B.A., Fox J.H. Use of the national adult reading test to estimate premorbid IQ in mild dementia. ClinNeuropsychol. 4:1990;18-24.
25. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state for the clinician. J Psychiat Res. 12:1975;189-198.
26. Dick J.P., Guiloff R.J., Stewart A., et al. Mini-mental state examination in neurological patients. J Neurol Neurosurg Psychiatry. 47:1984;496-499.
27. Mehta M.P., Shapiro W.R., Glantz M.J., et al. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol. 20:2002;3445-3453.
28. Archibald Y.M., Lunn D., Ruttan L.A., et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg. 80:1994;247-253.
29. Taphoorn M.J., Heimans J.J., Snoek F.J., et al. Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry. 55:1992;372-376.
30. Schmidinger M., Linzmayer L., Becherer A., et al. Psychometric- and quality-of-life assessment in long-term glioblastoma survivors. J Neurooncol. 63:2003;55-61.
31. Cull A., Hay C., Love S.B., Mackie M., Smets E., Stewart M. What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer. 74:1996;1674-1679.
32. Stewart AL, Ware JE, eds. Measuring functioning and well-being: the medical outcomes study approach. Durham, NC: Duke University Press, 1992.
33. DeAngelis L.M. Brain tumors. N Engl J Med. 344:2001;114-123.
34. Tucha O., Smely C., Preier M., Lange K.W. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery. 47:2000;324-333.
35. Scheibel R.S., Meyers C.A., Levin V.A. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol. 30:1996;61-69.
36. Hahn C.A., Dunn R.H., Logue P.E., King J.H., Edwards C.L., Halperin E.C. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys. 55:2003;992-999.
37. Anderson S.W., Damasio H., Tranel D. Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol. 47:1990;397-405.
38. Witte O.W. Lesion-induced plasticity as a potential mechanism for recovery and rehabilitative training. Curr Opin Neurol. 11:1998;655-662.
39. Feeney D.M., Baron J.C. Diaschisis. Stroke. 17:1986;817-830.
40. Barcelo F., Suwazono S., Knight R.T. Prefrontal modulation of visual processing in humans. NatNeurosci. 3:2000;399-403.
41. Price C.J., Warburton E.A., Moore C.J., Frackowiak R.S., Friston K.J. Dynamic diaschisis: anatomically remote and context-sensitive human brain lesions. J Cogn Neurosci. 13:2001;419-429.
42. Zappoli R., Zappoli F., Picchiecchio A., et al. Frontal and parieto-temporal cortical ablations and diaschisis-like effects on auditory neurocognitive potentials evocable from apparently intact ipsilateral association areas in humans: five case reports. Int J Psychophysiol. 44:2002;117-142.
43. Nguyen D.K., Botez M.I. Diaschisis and neurobehavior. Can J Neurol Sci. 25:1998;5-12.
44. Rozental J.M., Levine R.L., Nickles R.J., Dobkin J.A., Hanson J.M. Cerebral diaschisis in patients with malignant glioma. J Neurooncol. 8:1990;153-161.
45. Otte A., Roelcke U., von Ammon K., et al. Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine. J Neurol Sci. 156:1998;73-77.
46. Newberg A.B., Alavi A., Alavi J. Contralateral cortical diaschisis in a patient with cerebellar astrocytoma after radiation therapy. Clin Nucl Med. 25:2000;431-433.
47. Bruehlmeier M., Roelcke U., Amsler B., et al. Effect of radiotherapy on brain glucose metabolism in patients operated on for low grade astrocytoma. J Neurol Neurosurg Psychiatry. 66:1999;648-653.
48. Weiller C. Imaging recovery from stroke. Exp Brain Res. 123:1998;13-17.
49. Vikingstad E.M., Cao Y., Thomas A.J., Johnson A.F., Malik G.M., Welch K.M. Language hemispheric dominance in patients with congenital lesions of eloquent brain. Neurosurgery. 47:2000;562-570.
50. Ide C.F., Scripter J.L., Coltman B.W., Dotson R.S., Snyder D.C., Jelaso A. Cellular and molecular correlates to plasticity during recovery from injury in the developing mammalian brain. Prog Brain Res. 108:1996;365-377.
51. Duffau H., Capelle L., Denvil D., et al. Functional recovery after surgical resection of low grade gliomas in eloquent brain: hypothesis of brain compensation. J Neurol Neurosurg Psychiatry. 74:2003;901-907.
52. Duffau H., Capelle L., Denvil D., et al. Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg. 98:2003;764-778.
53. Reijneveld J.C., Sitskoorn M.M., Klein M., Nuyen J., Taphoorn M.J. Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology. 56:2001;618-623.
54. Crosley C.J., Rorke L.B., Evans A., Nigro M. Central nervous system lesions in childhood leukemia. Neurology. 28:1978;678-685.
55. Vigliani M.C., Duyckaerts C., Delattre J.Y. Radiation-induced cognitive dysfunction in adults. Vecht C.J. Handbook of clinical neurology. 1997;371-388 Elsevier Science, Amsterdam.
56. Sheline G.E., Wara W.M., Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 6:1980;1215-1228.
57. Armstrong C., Mollman J., Corn B.W., Alavi J., Grossman M. Effects of radiation therapy on adult brain behavior: evidence for a rebound phenomenon in a phase I trial. Neurology. 43:1993;1961-1965.
58. Armstrong C.L., Ruffer J., Corn B.W., DeVries K., Mollman J. Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol. 13:1995;2263-2271.
59. Vigliani M.C., Sichez N., Poisson M., Delattre J.Y. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Radiat Oncol Biol Phys. 35:1996;527-533.
60. Béhin A., Delattre J.Y. Neurologic sequelae of radiotherapy of the nervous system. Schiff D., Wen P.Y. Cancer neurology in clinical practice. 2003;173-192 Humana Press, Totowa.
61. Roman D.D., Sperduto P.W. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys. 31:1995;983-998.
62. Postma T.J., Klein M., Verstappen C.C., et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology. 59:2002;121-123.
63. Crossen J.R., Garwood D., Glatstein E., Neuwelt E.A. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 12:1994;627-642.
64. Monje M.L., Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol. 16:2003;129-134.
65. DeAngelis L.M., Delattre J.Y., Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology. 39:1989;789-796.
66. Arlt W., Hove U., Muller B., et al. Frequent and frequently overlooked: treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors. Neurology. 49:1997;498-506.
67. Taphoorn M.J.B., Heimans J.J., van der Veen E.A., Karim ABMF. Endocrine functions in long-term survivors of low-grade supratentorial glioma treated with radiation therapy. J Neurooncol. 25:1994;97-102.
68. Deijen J.B., de Boer H., van der Veen E.A. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology. 23:1998;45-55.
69. Taphoorn M.J., Schiphorst A.K., Snoek F.J., et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol. 36:1994;48-54.
70. Armstrong C.L., Hunter J.V., Ledakis G.E., et al. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology. 59:2002;40-48.
71. Torres I.J., Mundt A.J., Sweeney P.J., et al. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology. 60:2003;1113-1118.
72. Brown P.D., Buckner J.C., O'Fallon J.R., et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol. 21:2003;2519-2524.
73. Surma-aho O., Niemela M., Vilkki J., et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology. 56:2001;1285-1290.
74. Swennen MHJ, Bromberg JEC, Witkamp TD, Terhaard CHJ, Postma TJ, Taphoorn MJB. Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma. J Neurooncol (in press).
75. Gregor A., Cull A., Traynor E., Stewart M., Lander F., Love S. Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol. 41:1996;55-59.
76. Brown P.D., Buckner J.C., Uhm J.H., Shaw E.G. The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro-oncol. 5:2003;161-167.
77. Hochberg F.H., Slotnick B. Neuropsychologic impairment in astrocytoma survivors. Neurology. 30:1980;172-177.
78. Lieberman A.N., Foo S.H., Ransohoff J., et al. Long term survival among patients with malignant brain tumors. Neurosurgery. 10:1982;450-453.
79. Maire J.P., Coudin B., Guérin J., Caudry M. Neuropsychological impairment in adults with brain tumors. Am J Clin Oncol. 10:1987;156-162.
80. Asai A., Matsutani M., Kohno T., et al. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer. 63:1989;1962-1974.
81. Imperato J.P., Paleologos N.A., Vick N.A. Effects of treatment on long-term survivors with malignant gliomas. Ann Neurol. 28:1990;818-822.
82. Kleinberg L., Wallner K., Malkin M.G. Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys. 26:1993;129-133.
83. Trojanowski T., Peszynski J., Turowski K., et al. Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg. 70:1989;18-23.
84. Taylor B.V., Buckner J.C., Cascino T.L., et al. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol. 16:1998;2195-2201.
85. Laukkanen E., Klonoff H., Allan B., Graeb D., Murray N. The role of prophylactic brain irradiation in limited stage small cell lung cancer: clinical, neuropsychological and CT sequelae. Int J Radiat Oncol Biol Phys. 14:1988;1109-1117.
86. Komaki R., Meyers C.A., Shin D.M., et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys. 33:1995;179-182.
87. Van Oosterhout A.G.M., Boon P.J., Houx P.J., ten Velde G.P.M., Twijnstra A. Follow-up of cognitive functioning in patients with small cell lung cancer. Int J Radiat Oncol Biol Phys. 31:1995;911-914.
88. Vines E.F., Le Pechoux C., Arriagada R. Profylactic irradiation in small-cell lung cancer. Sem Oncol. 30:2003;38-46.
89. Posner J.B. Paraneoplastic syndromes. Posner JB. "Neurologic complications of cancer. 1995;353-385 FA Davis Company, Philadelphia.
90. Abrey L.E., DeAngelis L.M., Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol. 16:1998;859-863.
91. Wassenberg W.M., Bromberg J.E.C., Witkamp T.D., Terhaard C.H.J., Taphoorn M.J. White matter lesions and encephalopathy in patients treated for primary central nervous system lymphoma. J Neurooncol. 52:2001;73-80.
92. DeAngelis L.M. Primary central nervous system lymphoma. J Neurol Neurosurg Psychiatry. 66:1999;699-701.
93. Fliessbach K., Urbach H., Helmstaedter C., et al. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Arch Neurol. 60:2003;563-568.
94. Lee P.W., Hung B.K., Woo E.K., Tai P.T., Choi D.T. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry. 52:1989;488-492.
95. Drane L.D., Meador K.J. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav. 3:2002;49-53.
96. Meador K.J. Cognitive outcomes and predictive factors in epilepsy. Neurology. 58:2002;21-26.
97. Jokeit H., Ebner A. Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study. J Neurol Neurosurg Psychiatry. 67:1999;44-50.
98. Dodrill C.B. Progressive cognitive decline in adolescents and adults with epilepsy. Prog Brain Res. 135:2002;399-407.
99. Levin V.A. Neuro-oncology: an overview. ArchNeurol. 56:1999;401-404.
100. Cairncross G., Macdonald D., Ludwin S., et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol. 12:1994;2013-2021.
101. Yung W.K., Prados M.D., Yaya-Tur R., et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol. 17:1999;2762-2771.
102. Keime-Guibert F., Napolitano M., Delattre J.Y. Neurological complications of radiotherapy and chemotherapy. J Neurol. 245:1998;695-708.
103. Wen P.Y. Central nervous system complications of cancer therapy. Schiff D., Wen P.Y. Cancer neurology in clinical practice. 2003;215-231 Humana Press, Totowa.
104. Shapiro W.R., Green S.B. Reevaluating the efficacy of intra-arterial BCNU. J Neurosurg. 66:1987;313-315.
105. Shapiro W.R., Green S.B., Burger P.C., et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg. 76:1992;772-781.
106. Philips P.C. Methotrexate toxicity. Rottenberg D.A. Neurological complications of cancer treatment. 1991;115-134 Butterworth-Heinemann, Boston.
107. DeAngelis L.M., Yahalom J., Thaler H.T., Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol. 10:1992;635-643.
108. Shapiro W.R., Chernik N.L., Posner J.B. Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol. 28:1973;96-102.
109. Boogerd W., vd Sande J.J., Moffie D. Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate. J Neurol Neurosurg Psychiatry. 51:1988;1277-1283.
110. Postma T.J., van Groeningen C.J., Witjes R.J., Weerts J.G., Kralendonk J.H., Heimans J.J. Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma. J Neurooncol. 38:1998;69-75.
111. Rosenblum M.K., Delattre J.Y., Walker R.W., Shapiro W.R. Fatal necrotizing encephalopathy complicating treatment of malignant gliomas with intra-arterial BCNU and irradiation: a pathological study. J Neurooncol. 7:1989;269-281.
112. Hwang T.L., Yung W.K., Estey E.H., Fields W.S. Central nervous system toxicity with high-dose Ara-C. Neurology. 35:1985;1475-1479.
113. Herzig R.H., Hines J.D., Herzig G.P., et al. Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol. 5:1987;927-932.
114. Gangji D., Reaman G.H., Cohen S.R., Bleyer W.A., Poplack D.G. Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med. 303:1980;19-21.
115. Boogerd W. Neuro-oncologic complications of breast cancer. Schiff D., Wen P.Y. Cancer neurology in clinical practice. 2003;309-325 Humana Press, Totowa.
116. Van Dam F.S., Schagen S.B., Muller M.J., et al. Impairment of cognitive function in women receiving adjuvant treatment of high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst. 90:1998;210-218.
117. Brezden C.B., Philips K.A., Abdolell M., Bunston T., Tannock I.F. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 18:2000;2695-2701.
118. Schagen S.B., Muller M.J., Boogerd W., et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol. 13:2002;1387-1397.
119. Ahles T.A., Saykin A.J., Furstenberg C.T., et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 20:2002;485-493.
120. Pavol M.A., Meyers C.A., Rexer J.L., Valentine A.D., Mattis P.J., Talpaz M. Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology. 45:1995;947-950.
121. Harder H., Cornelissen J.J., van Gool A.R., Duivenvoorden H.J., Eijkenboom W.M., van den Bent M.J. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer. 95:2002;183-192.
122. Varney N.R., Alexander B., MacIndoe J.H. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry. 141:1984;369-372.
123. Anderson S.I., Taylor R., Whittle I.R. Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg. 13:1999;480-485.
124. Lilja A., Hagstadius S., Risberg J., Salford L.G., Smith G.J.W., Ohman R. Frontal lobe dynamics in brain tumor patients: a study of regional blood flow and affective changes before and after surgery. Neuropsychiat Neuropsychol Behav Neurol. 5:1992;294-300.
125. Andrewes D.G., Kaye A., Murphy M., et al. Emotional and social dysfunction in patients following surgical treatment for brain tumour. J Clin Neurosci. 10:2003;428-433.
126. Thiessen B., DeAngelis L.M. Hydrocephalus in radiation leukoencephalopathy. Arch Neurol. 55:1998;705-710.
127. Meyers C.A., Weitzner M.A., Valentine A.D., Levin V.A. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 16:1998;2522-2527.
128. Hulshof M.C., Stark N.M., van der Kleij A., Sminia P., Smeding H.M., Gonzalez Gonzalez D. Hyperbaric oxygen therapy for cognitive disorders after irradiation of the brain. Strahlenther Onkol. 178:2002;192-198.
129. Sherer M., Meyers C.A., Bergloff P. Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer. 80:1997;250-257.
130. Davies E., Hall S., Clarke C. Two year survival after malignant cerebral glioma: patient and relative reports of handicap, psychiatric symptoms and rehabilitation. Disabil Rehabil. 25:2003;259-266.
131. Butler R.W., Copeland D.R. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc. 8:2002;115-124.
132. Engelberts N.H., Klein M., Ader H.J., Heimans J.J., Trenite D.G., van der Ploeg H.M. The effectiveness of cognitive rehabilitation for attention deficits in focal seizures: a randomized controlled study. Epilepsia. 43:2002;587-595.